Lysosomal Alpha Glucosidase Market–Top Participant To Focus On Regional Expansion
The GAA gene in humans codes for the enzyme lysosomal alpha-glucosidase. It's also known as glucosidase-1, 4-glucosidase, and acid maltase. Glycogen storage disease type II and Pompe disease are caused by abnormalities in this gene. This gene produces acid alpha-glucosidase, which is required for the conversion of glycogen to glucose in lysosomes. Different types of acid alpha-glucosidase can be obtained through proteolytic processing. This gene has three transcript variants that all code for the same protein. Glycogen storage disease and Pompe disease are treated with lysosomal alpha-glucosidase. The rising prevalence of disorders such as glycogen storage disease and Pompe disease, as well as the growing population, are driving the market for lysosomal alpha glucosidase. Lysosomal Alpha Glucosidase Market- Regional Analysis The lysosomal alpha glucosidase market has been divided into North America, Latin America, Europe, the Middle East, Asia Pacific, and Africa based on geograph...